secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2026-06-16T11:00:33+00:00
Accession:  0001104659-26-074292
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PTC Therapeutics prices $500M 0% convertible notes due 2031 to refinance 2026 notes
--------------------------------------------------------------------------------

- Priced $500M aggregate principal of 0% Convertible Senior Notes due 2031; initial purchasers have option for additional $50M.
- Conversion price set at $107.48 per share, a 40% premium over June 15 closing price of $76.77.
- Approximately $328.8M of net proceeds will be used to repurchase $222M of outstanding 1.5% convertible notes due 2026.
- Closing expected on June 18, 2026; notes are senior unsecured obligations and mature June 15, 2031.
- Remaining net proceeds will be used for general corporate purposes, including potential additional repurchases of 2026 notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000110465926074292/0001104659-26-074292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000110465926074292/tm2618041d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-074292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer